Seelos Therapeutics, Inc.: capex
| Value | {"amount": 18000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2016-01-01 – 2016-06-30 |
| Status | current |
| Entity | Seelos Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:53:13.881238+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a99e0a9f-b486-4f2a-9b37-6a5277bcdae0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001017491-16-000215 · Open the official SEC filing →Retrieved: 2026-08-19T09:53:13.881238+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001017491/capex/2016-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a99e0a9f-b486-4f2a-9b37-6a5277bcdae0
History
- no predecessors — first report